Entrectinib as a Single Agent in Upfront Therapy for Children <3 Years of Age With NTRK1/2/3 or ROS1-FUSED CNS Tumors
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
Children's Oncology Group
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Massachusetts General Hospital
Children's Oncology Group
City of Hope Medical Center
St. Jude Children's Research Hospital
Children's Oncology Group
St. Jude Children's Research Hospital
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
St. Jude Children's Research Hospital
Albert Einstein College of Medicine
OHSU Knight Cancer Institute
New Approaches to Neuroblastoma Therapy Consortium
Children's Hospital Los Angeles
New Approaches to Neuroblastoma Therapy Consortium
Children's Oncology Group
Children's Oncology Group
Barbara Ann Karmanos Cancer Institute
St. Anna Kinderkrebsforschung
Emory University
Children's Oncology Group
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Children's Oncology Group
St. Jude Children's Research Hospital
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Children's Oncology Group
Children's Oncology Group
Children's Oncology Group
Children's Oncology Group
Children's Oncology Group
Children's Oncology Group
Children's Oncology Group
Children's Oncology Group
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Children's Oncology Group
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Dana-Farber Cancer Institute
National Institutes of Health Clinical Center (CC)